Business

New start-up companies are constantly commercialising new technologies and services. Genomics is ripe for investment right now.

CRISPR-Focused Companies Take Stock Dive

Shares in various companies using gene editing technologies fell earlier this week, after it was widely reported that CRISPR may raise the risk of cancer in edited cell populations.

London Calling: It’s Oxford Nanopore

For all the nanopore enthusiasts and aficionados out there, London Calling is the highlight of the year. Taking place in May, the show is everything you’d expect from a company that takes such care with its growing community of users.